Cargando…

Sentinel inflammatory demyelinating lesions preceding primary CNS lymphoma

Detalles Bibliográficos
Autores principales:	TORRES, Danielle Mesquita, PITOMBEIRA, Milena Sales, SANTIAGO, Igor Bessa, MARTINS, Gabriela Joca, FERMON, Kellen Paiva, TAVORA, Daniel Gurgel Fernandes, CARVALHO, Fernanda Martins Maia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academia Brasileira de Neurologia - ABNEURO 2021
Materias:	Images in Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394580/ https://www.ncbi.nlm.nih.gov/pubmed/34190816 http://dx.doi.org/10.1590/0004-282X-anp-2020-0394

Ejemplares similares

Demyelinating sentinel lesion preceding a primary central nervous system lymphoma
por: Sprenger, Flávia, et al.
Publicado: (2021)

Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination
por: Kvarta, Mark D., et al.
Publicado: (2016)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Deciphering the Footprints of Autoimmunity in CNS Demyelinating Disorders
por: Netravathi, M
Publicado: (2022)

Blood-brain barrier hyperpermeability precedes demyelination in the cuprizone model
por: Berghoff, Stefan A., et al.
Publicado: (2017)

Cuprizone does not induce CNS demyelination in nonhuman primates
por: Chen, Zhihong, et al.
Publicado: (2015)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
por: Kim, Sung-Min, et al.
Publicado: (2015)

Challenges in the diagnosis and treatment of CNS demyelinating disorders in Zambia
por: Miskin, Dhanashri P, et al.
Publicado: (2016)

Effects of CNS Demyelination and Myelin Recovery on Urinary Physiology
por: Ramasamy, Ramalakshmi, et al.
Publicado: (2020)

Anterior optic pathway pathology in CNS demyelinating diseases
por: Pisa, Marco, et al.
Publicado: (2022)

Clinical Features and Inflammatory Markers in Autoimmune Encephalitis Associated With Antibodies Against Neuronal Surface in Brazilian Patients
por: Nóbrega, Paulo Ribeiro, et al.
Publicado: (2019)

Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease
por: Chastain, Emily M. L., et al.
Publicado: (2012)

MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination
por: Tietz, Silvia M., et al.
Publicado: (2014)

Asymptomatic CNS demyelination related to TNF-α inhibitor therapy
por: Ali, Farwa, et al.
Publicado: (2016)

alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
por: Kuhbandner, Kristina, et al.
Publicado: (2020)

CNS-disseminated Angiostrongylus cantonensis mimicking atypical demyelinating disease
por: Long, Daniel, et al.
Publicado: (2019)

Developmental ablation of mature oligodendrocytes exacerbates adult CNS demyelination
por: Pajoohesh-Ganji, Ahdeah, et al.
Publicado: (2020)

Development of a PET radioligand for potassium channels to image CNS demyelination
por: Brugarolas, Pedro, et al.
Publicado: (2018)

16. A rare case of CNS demyelination with anti-TNF treatment
por: Chakravorty, Mithun, et al.
Publicado: (2018)

Acute and chronic demyelinated CNS lesions exhibit opposite elastic properties
por: Urbanski, Mateusz M., et al.
Publicado: (2019)

Murine hepatitis virus—A model for virus-induced CNS demyelination
por: Matthews, A. E., et al.
Publicado: (2002)

Coronavirus-induced CNS disease: A model for virus-induced demyelination
por: Buchmeier, Michael J., et al.
Publicado: (1988)

Association of CNS demyelination and COVID-19 infection: an updated systematic review
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2021)

Innate Signaling in the CNS Prevents Demyelination in a Focal EAE Model
por: Dubik, Magdalena, et al.
Publicado: (2021)

Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease
por: Denny, Lisa, et al.
Publicado: (2021)

COVID-19 and the risk of CNS demyelinating diseases: A systematic review
por: Lotan, Itay, et al.
Publicado: (2022)

Mechanisms of antigen-induced reversal of CNS inflammation in experimental demyelinating disease
por: Li, Jian, et al.
Publicado: (2023)

Coccidioidomycosis in a reference center in Northeast Brazil: clinical/epidemiological profile and most common radiological findings
por: Morais, José Leonardo da Silveira, et al.
Publicado: (2020)

Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma
por: Bajagain, Madan, et al.
Publicado: (2020)

Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study
por: Ketelslegers, I. A., et al.
Publicado: (2012)

Acquired CNS Demyelinating Syndrome in Children Referred to ShirazPediatric Neurology Ward
por: INALOO, Soroor, et al.
Publicado: (2014)

Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB
por: Rusielewicz, Tomasz, et al.
Publicado: (2014)

Influenza Vaccine-Induced CNS Demyelination in a 50-Year-Old Male
por: Sacheli, Aaron, et al.
Publicado: (2014)

Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
por: Thompson, Kaitlyn K., et al.
Publicado: (2018)

Zika Virus Infection Leads to Demyelination and Axonal Injury in Mature CNS Cultures
por: Schultz, Verena, et al.
Publicado: (2021)

A systematic review of cases of CNS demyelination following COVID-19 vaccination
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2022)

CNS demyelination associated with immune dysregulation and a novel CTLA-4 variant
por: Kaninia, Stefania, et al.
Publicado: (2021)

Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_28b5e9hc4s16l5a51f10imka50